Average Co-Inventor Count = 5.75
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Glenmark Specialty S.a. (9 from 24 patents)
2. Glenmark Pharmaceuticals Limited (3 from 33 patents)
12 patents:
1. 12514996 - Metered dose inhalers of fluticasone or an ester thereof
2. 12514995 - Metered dose inhalers of fluticasone or an ester thereof
3. 12303635 - Dispensing device and pharmaceutical composition for the treatment of rhinitis
4. 11679210 - Dispensing device and pharmaceutical composition for the treatment of rhinitis
5. 10765686 - Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
6. 10561672 - Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
7. 10517880 - Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
8. 10376526 - Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
9. 9937189 - Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
10. 9750754 - Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
11. 9370483 - Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
12. 9078923 - Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine